Fingerprint
Dive into the research topics of 'A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children’s Oncology Group Study ADVL1412'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically